Melatonin increased hypoxia-inducible factor (HIF) by inhibiting prolyl hydroxylase: A hypothesis for treating anaemia, ischaemia, and covid-19.

Hosseinzadeh, Mohammad Hossein; Goodarzi, Amin; Malekan, Mohammad; Ebrahimzadeh, Mohammad Ali

Hosseinzadeh, Mohammad Hossein; Goodarzi, Amin; Malekan, Mohammad; Ebrahimzadeh, Mohammad Ali.

Hosseinzadeh MH; Pharmaceutical Sciences Research Center, School of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.
Goodarzi A; Department of Medicinal Chemistry, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.
Malekan M; Student Research Committee, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
Ebrahimzadeh MA; Pharmaceutical Sciences Research Center, School of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.

Clin Exp Pharmacol Physiol ; 49(6): 696-698, 2022 06.

Article in English | MEDLINE | ID: covidwho-1853513

Subject(s)

Anemia; COVID-19; Melatonin; Anemia/drug therapy; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Ischemia; Melatonin/pharmacology; Melatonin/therapeutic use; Prolyl Hydroxylases

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Anemia / Melatonin Limits: Humans Language: English Journal: Clin Exp Pharmacol Physiol Year: 2022 Document Type: Article Affiliation country: 1440-1681.13639

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google